99 Wall Street, Suite 232, New York, NY 10005

Need Help? Call : (800) 991-3756

Class Action Cases

A class action has been filed on behalf of Mallinckrodt plc Investors. Click "Join this Class Action" above.

Attorneys

Mallinckrodt plc

Join Class Action »

Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Mallinckrodt plc (NYSE: MNK) from February 28, 2018 through July 16, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Mallinckrodt investors under the federal securities laws.

If you bought Mallinckrodt securities between February 28, 2018 and July 16, 2019, and would like to join the action, please click “Join This Class Action,” above.

Press Release

SHAREHOLDER ALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Mallinckrodt plc – MNK

New York, N.Y., July 30, 2019. Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Mallinckrodt plc (NYSE: MNK) from February 28, 2018 through July 16, 2019, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Mallinckrodt investors under the federal securities laws.

To join the Mallinckrodt class action, go to http://zhanginvestorlaw.com/cases/mallinckrodt-plc/ or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) H.P. Acthar Gel (“Acthar”) posed significant safety concerns that rendered it a non-viable treatment for ALS; (2) accordingly, Mallinckrodt overstated the viability of Acthar as an ALS treatment; and (3) as a result, Mallinckrodt’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 24, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://zhanginvestorlaw.com/cases/mallinckrodt-plc/ or to discuss your rights or interests regarding this class action, please contact Sophie Zhang, Esq. of Zhang Investor Law toll free at 800-991-3756 or via e-mail at info@zhanginvestorlaw.com.

Zhang Investor Law represents investors worldwide.
——————————-